How a Disrupted Gut Microbiome May Drive Metabolic Kidney Disease
A new review details how gut microbiome disruption may drive metabolic dysfunction-associated kidney disease through microbial metabolites, inflammation, and barrier ...
A new review details how gut microbiome disruption may drive metabolic dysfunction-associated kidney disease through microbial metabolites, inflammation, and barrier ...
A comprehensive narrative review maps how age-related changes in gut microbial metabolism — from short-chain fatty acids to bile acids ...
A detailed multi-omics study of 75 vegans and 75 omnivores reveals that a plant-based diet is linked to a coordinated ...
A pooled analysis of two placebo-controlled crossover trials shows that the SGLT-2 inhibitors empagliflozin and dapagliflozin modestly but significantly raise ...
A machine learning-based systematic review of 179 studies traces how the milk bioactives carnitine and betaine link ruminant metabolism, infant ...
New research shows the diabetes drug empagliflozin protects against experimental abdominal aortic aneurysm by reshaping the gut microbiome and strengthening ...
A comprehensive review finds that gut microbial imbalance drives metabolic, neurodegenerative, cardiovascular and gastrointestinal diseases through defined metabolite signaling pathways.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine